CN104364378A - 制备重组肽的方法 - Google Patents

制备重组肽的方法 Download PDF

Info

Publication number
CN104364378A
CN104364378A CN201380025049.6A CN201380025049A CN104364378A CN 104364378 A CN104364378 A CN 104364378A CN 201380025049 A CN201380025049 A CN 201380025049A CN 104364378 A CN104364378 A CN 104364378A
Authority
CN
China
Prior art keywords
peptide
vsdl
cleavage site
fusion polypeptide
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380025049.6A
Other languages
English (en)
Chinese (zh)
Inventor
斯坦·巴斯蒂拉斯
安吉洛·圭多林
本·亨特
赛义夫·莱希德
雷扎·扎雷尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madeleine Pharmaceuticals Pty Ltd
Original Assignee
Madeleine Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madeleine Pharmaceuticals Pty Ltd filed Critical Madeleine Pharmaceuticals Pty Ltd
Priority to CN201710409638.4A priority Critical patent/CN107266554A/zh
Publication of CN104364378A publication Critical patent/CN104364378A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201380025049.6A 2012-03-19 2013-03-19 制备重组肽的方法 Pending CN104364378A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710409638.4A CN107266554A (zh) 2012-03-19 2013-03-19 制备重组血管扩张肽的方法、表达构建体、宿主细胞及重组融合多肽

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612817P 2012-03-19 2012-03-19
US61/612,817 2012-03-19
PCT/AU2013/000273 WO2013138850A1 (en) 2012-03-19 2013-03-19 Method of producing a recombinant peptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201710409638.4A Division CN107266554A (zh) 2012-03-19 2013-03-19 制备重组血管扩张肽的方法、表达构建体、宿主细胞及重组融合多肽

Publications (1)

Publication Number Publication Date
CN104364378A true CN104364378A (zh) 2015-02-18

Family

ID=49221695

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380025049.6A Pending CN104364378A (zh) 2012-03-19 2013-03-19 制备重组肽的方法
CN201710409638.4A Pending CN107266554A (zh) 2012-03-19 2013-03-19 制备重组血管扩张肽的方法、表达构建体、宿主细胞及重组融合多肽

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201710409638.4A Pending CN107266554A (zh) 2012-03-19 2013-03-19 制备重组血管扩张肽的方法、表达构建体、宿主细胞及重组融合多肽

Country Status (8)

Country Link
US (1) US20150315259A1 (cg-RX-API-DMAC7.html)
EP (1) EP2839010B1 (cg-RX-API-DMAC7.html)
JP (1) JP2015510770A (cg-RX-API-DMAC7.html)
KR (1) KR20140148420A (cg-RX-API-DMAC7.html)
CN (2) CN104364378A (cg-RX-API-DMAC7.html)
AU (2) AU2013234860B2 (cg-RX-API-DMAC7.html)
SG (1) SG11201405721VA (cg-RX-API-DMAC7.html)
WO (1) WO2013138850A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11867729B2 (en) 2009-05-26 2024-01-09 Solaredge Technologies Ltd. Theft detection and prevention in a power generation system

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
CN113121637B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种重组蛋白的分离纯化方法
CN116981680A (zh) 2021-01-14 2023-10-31 生物催化剂有限责任公司 用于肽生产的组合物和方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716790D0 (en) * 1997-08-07 1997-10-15 Creative Peptides Sweden Ab Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
CN1242062C (zh) * 1998-07-10 2006-02-15 赛欧斯公司 生产等电点高于8或低于5的多肽的方法
AU5762699A (en) * 1998-09-19 2000-04-10 Sang Jun Lee Dna cassette encoding a multimer of a biologically active peptide and a cleavable linker attached thereto and process for preparing the biologically active peptide
US6759510B1 (en) * 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
CN1363654A (zh) * 2001-07-19 2002-08-14 上海华谊生物技术有限公司 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法
ATE457355T1 (de) * 2002-05-24 2010-02-15 Medtronic Inc Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute
SG159387A1 (en) * 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof
EP1727556A2 (en) * 2004-02-17 2006-12-06 University Of South Florida Materials and methods for treatment of inflammatory and cell proliferation disorders
EP1736480B9 (en) * 2005-06-02 2009-03-04 Polyquant GmbH Artificial protein, method for absolute quantification of proteins and uses thereof
WO2009043468A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of corticotropin-releasing factor as a therapeutic agent
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
US8527211B2 (en) * 2008-06-18 2013-09-03 Reza Zareie Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization
CN102575264A (zh) * 2009-09-18 2012-07-11 瑟莱克斯公司 增加的转基因表达和加工的产品和方法
WO2012019237A1 (en) * 2010-08-12 2012-02-16 Madeleine Pharmaceuticals Pty Ltd Therapeutic method for treating congestive heart failure
EP2678002A2 (en) * 2011-02-25 2014-01-01 Medtronic, Inc. Therapy for kidney disease and/or heart failure

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
徐小寅: "Alloferon-1抗菌肽串联式重组表达及重组Alloferon-1生物学活性研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》, 15 July 2011 (2011-07-15) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11867729B2 (en) 2009-05-26 2024-01-09 Solaredge Technologies Ltd. Theft detection and prevention in a power generation system

Also Published As

Publication number Publication date
JP2015510770A (ja) 2015-04-13
AU2013234860B2 (en) 2016-01-21
US20150315259A1 (en) 2015-11-05
AU2013234860A1 (en) 2014-10-16
SG11201405721VA (en) 2014-10-30
EP2839010A1 (en) 2015-02-25
AU2016100212A4 (en) 2016-04-14
EP2839010B1 (en) 2018-04-25
KR20140148420A (ko) 2014-12-31
EP2839010A4 (en) 2015-12-09
CN107266554A (zh) 2017-10-20
WO2013138850A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
CN104619726B (zh) 由超折叠绿色荧光蛋白构成的融合蛋白及其用途
US8796431B2 (en) Efficient production of peptides
US8298789B2 (en) Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
JP2008539696A (ja) 融合タンパク質の分離のための組成物および方法
AU2016100212A4 (en) Method of producing a recombinant peptide
CN103025875A (zh) 原核表达构建体
JP7266325B2 (ja) 蛍光タンパク質フラグメントを含む融合タンパク質およびその用途
WO2021147869A1 (zh) 利拉鲁肽衍生物及其制备方法
JP5331685B2 (ja) 二塩基性b鎖末端を有するインスリン類似体の生産方法
CN104387473B (zh) 用于非酶切非色谱纯化方法原核表达融合蛋白Prx的类弹性蛋白多肽ELP
JP2018502908A (ja) アルファ‐1‐ アンチトリプシン(a1at)融合タンパク質及びその使用
EP3741774A1 (en) N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
WO2021249564A1 (zh) 一种索玛鲁肽衍生物及其制备方法和应用
CN113773400B (zh) 一种门冬胰岛素衍生物及其应用
CN101948837A (zh) 在重组大肠杆菌中生产人的类胰岛素生长因子-1的方法
CN100418983C (zh) 人胰高血糖素相关肽-2类似物
RU2801248C2 (ru) Гибридный белок, содержащий фрагменты флуоресцентных белков, и его применение
KR102345013B1 (ko) GroES 융합을 이용한 글루카곤 유사 펩타이드-2 또는 이의 유사체의 생산방법
Du et al. Expression and purification of soluble recombinant human endostatin in Escherichia coli
KR20150089499A (ko) 대량 생산이 가능하도록 개선된 경구투여용 트롬보포이에틴 및 이의 대량 생산공정

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150218

RJ01 Rejection of invention patent application after publication